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A B S T R A C T
The aim of the present study was to investigate the pancreatic regeneration potential of of 
diferent fractions of the ethanol extract Clitoria ternatea L., Fabaceae. The antidiabetic and 
antihyperlipidemic potential was evaluated in streptozotocin-induced diabetic rats and 
correlated with its in vivo and in vitro antioxidant activity. The extract and its fractions were 
initially screened for acute and sub-chronic antidiabetic activity in the dose range of 100-
200 mg/kg. The most potent extract and fractions were further evaluated for pancreatic 
β-cells regeneration activity along with antioxidant and antihyperlipidemic activity. The 
polyphenolic, flavonoid and flavanone contents were assessed and correlated with its 
antidiabetic activity. The most significant pancreatic regeneration activity, antidiabetic and 
antihyperlipidemic activity and was shown by ethanol extract and butanol soluble fraction at 
a dose level of 200 mg/kg, while rutin was found to be least potent. In conclusion, pancreatic 
regeneration studies of ethanol extract treated rats show nesidioblastosis. It is also suggested 
that the factors causing regeneration are present within the pancreas. The newly generated 
islets may have formed from the ductal precursor cells and reduced oxidative stress helps in 
restoration of β-cell function.
© 2013 Elsevier Editora Ltda. 
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Introduction
Diabetes mellitus (DM) is a major endocrine disorder, affecting 
approximately 5% of the world’s population. Oxidative stress 
is one of the main factors associated to the development of 
glucose toxicity in diabetes since it causes decrease in levels 
of two critical transcription factors, PDX-1 and MafA. These 
normally bind to the insulin promoter and stimulate insulin 
gene transcription, decreased levels of these two proteins cause 
decrease in insulin promoter activity, insulin gene expression 
and insulin secretion (Robertson and Harmon, 2006). 
Many of oral antidiabetic drugs provide only symptomatic 
relief and do not actively treat diabetes. An alternative strategy 
for diabetes treatment is the use of various plant extracts 
and herbal biomolecules, for their pancreas regeneration 
properties. Detailed investigations of the mechanism of 
action of these biomolecule have revealed that some of them 
allow the regeneration of β-cells, thus causing a reversal of 
diabetes in human and non-human subjects. For example, 
chard extract (Beta vulgaris L. var. cicla) has been used as a 
hypoglycaemic agent by DM patients in Turkey (Bolkent 
et al., 2000) and it has been documented that the number of 
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β-cells and secretory granules increase after treatment with 
this herbal extract. Similarly various phytoconstituent such 
as epicatechin, rutin, quercetin, nymphayol and flavonoid 
extracts from Pterocarpus marsupium have shown to possess 
β-cells regeneration capacity (Chakravarthy et al., 1980;1981; 
Limbert et al., 2008; Subash-Babu et al., 2009). Flavonoids 
represent the most common and widely distributed group of 
plant phenolics (Harborne, 1986) and are abundant in foods; 
quercetin and rutin are the flavonoids most abundantly 
consumed (Nakamura et al., 2000).
Clitoria ternatea L., Fabaceae, is a highly nutritious legume 
used a livestock forage plant in many countries (Gomez and 
Kalamani, 2003; Hall, 1992) and is one of the most widely used 
herbal medicines in India. Phytochemical investigations of C. 
ternatea revealed the presence of flavonoid glycosides such 
as rutin, delphidin, kaempferol, quercetin and malvidin, and 
it has been documented that its leaves contain δ-lactone of 
2-methyl-4-hydroxy-n-pentacosanoic acid. This plant is 
commonly used in the Ayurvedic medicine, as a memory 
enhancer, nootropic, anxiolytic, antidepressant, tranquilizing 
and sedative agent. Its extracts possess a wide range of 
pharmacological activities including antimicrobial, antipyretic, 
anti-inflammatory, antiasthmatic, hepatoprotective analgesic, 
diuretic, local anesthetic, antidiabetic, insecticidal, blood 
platelet aggregation-inhibiting and for use as a vascular smooth 
muscle relaxing properties (Kalyan et al., 2011; Nithianantham 
et al., 2013; Taur and Patil, 2011; Mukherjee et al., 2008)
Aqueous and ethanol extracts of roots, leaves and flowers 
have been previously studied for its antidiabetic potential, the 
mechanism of action and effect of flavonoid rich fraction of 
plant on pancreatic regeneration property was not evaluated 
keeping the above information in view (Daisy et al., 2009; 
Mukherjee et al., 2008).
The present study aimed to investigate the pancreatic 
regeneration potential of the different fractions of the ethanol 
extracts, in comparison to the flavonoid rutin. The antidiabetic 
and antihyperlipidemic potentials were also evaluated in 
streptozotocin-induced diabetic rats and correlated with its 
antioxidant activity and pancreatic regeneration activity.
Materials and methods
Animals
Male Swiss albino rats of Sprague-Dawley strain (175-200 g) 
were obtained from our institute’s animal housing facility. 
The animals were fed a standard pellet diet and water was 
administered ad libitum. They were maintained in a controlled 
laboratory environment (22 ± 5 ºC, 12 h of light/dark cycle). 
All experimental protocols were approved by the Institutional 
Animal Ethical Committee (23/2009/CPCSEA).
Plant material, preparation of extract and its fractionation
The aerial parts of Clitoria ternatea L., Fabaceae, were collected 
locally and authenticated by the Department of Botany, R. T. M. 
Nagpur University Campus, Nagpur. A voucher specimen was 
deposited in the Herbarium of the Department of Botany, with 
collection number RA 9778. The aerial parts were dried under 
shade and pulverized into a coarse powder. The powdered 
crude material was defatted with petroleum ether and then 
extracted with ethanol. The ethanol extract (CTAE) was 
concentrated in a rotary vacuum evaporator to yield a dark 
brown mass (yield 20.78% w/w). For fractionation, the ethanol 
extract was subjected to liquid-liquid partition with chloroform 
to yield a chloroform soluble fraction (CTACS; yield: 18.92% 
w/w) and a chloroform insoluble fraction. The chloroform 
insoluble fraction was further fractionated with n-butanol to 
yield a n-butanol soluble fraction (CTABS; yield: 55.83% w/w) 
and a n-butanol insoluble fraction (CTABIS; yield: 25.25% w/w). 
The ethanol extracts (CTAE) and these three broad fractions i.e. 
CTACS, CTABS and CTABIS were subjected to phytochemical 
and pharmacological screening.
Phytochemical screening
The CTAE extract and its broad fractions were screened 
for the presence of tannins, saponins, unsaturated sterols, 
triterpenes, alkaloids, flavonoids, lactones/esters, protein/
amino acids, carbohydrates and/or glycosides, using thin layer 
chromatography (TLC) (Stahl, 1969). Thin layer plates pre-
coated with silica gel G (Merck, 0.25 mm thickness) were used. 
Development was carried out with different solvent systems 
such as ethyl acetate: methanol: water (100:13.5:10, v/v/v), ethyl 
acetate:formic acid:acetic acid:water (100:11:11:26, v/v/v/v), 
toluene:methanol (80:20, v/v), toluene:ethyl acetate:formic 
acid (78:18:4, v/v/v) and ethyl acetate:methanol:water:acetic 
acid (65:15:15:10, v/v/v/v). After development of chromatogram, 
the plates were dried and sprayed with Dragendorff’s, AlCl3, 
hydroxylamine-ferric chloride solution, ninhydrin and 
antimony trichloride for the detection of alkaloids, flavonoids, 
lactones/esters, protein/amino acids, unsaturated sterols and 
triterpenes respectively. While detection of anthraquinones, 
saponins, tannins, carbohydrate and/or glycosides used KOH, 
anisaldehyde-sulphuric acid reagent, ferric chloride and 
naphthoresorcinol reagent respectively. Visualization was 
carried out under visible and UV light (λ 366 nm). CTAE extract 
and its fractions were also quantified for presence of important 
secondary metabolites such as total polyphenol, flavonoid and 
flavonone compounds, using following spectroscopic methods.
Determination of total polyphenol contents (TP), flavonoids 
(TFA) and total flavanones (TFO)
Total polyphenol content was measured using the Folin-
Ciocalteu colorimetric method (Singlenton et al., 1999). Gallic 
acid was used as a reference for standard curve construction. 
The results were expressed as mg of gallic acid equivalents 
(GAE)/g of extract. Flavonoid content was determined by the 
aluminium chloride method (Stanojeviđ et al., 2009). Rutin 
was used as a reference for standard curve construction. 
The results were expressed as mg of rutin equivalents (RE)/g 
of extract. For determination of flavanones the modified 
2,4-dinitrophenylhydrazine method was used (Nagy and 
Grancai, 1996). Naringin was used as a reference standard and 
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results were expressed as mg of naringin equivalents (NE)/g 
of extract. All determinations were carried out in triplicate.
Quantitative estimation of rutin by HPTLC (Gupta et al., 2006)
Crude extracts and its fractions were standardized in relation 
to their rutin content using HPTLC . Ten microliter of test and 
standard solutions were applied on a pre-coated silica gel G 
60 F254 TLC plate (E. Merck). Chromatogram was developed in 
ethyl acetate:formic acid:ethanol:water (100:11:11:26) (Marston 
and Hostettmann, 2006), visualized at 366 nm and compared 
against rutin standard for quantification using area under the 
curve method.
In vitro antioxidant studies
The antioxidant activities of rutin, ethanol extract and its 
fractions were assessed by 2, 2-diphenyl-1-picrylhydrazyl 
(DPPH) method (Sharma and Bhat, 2009) and nitric oxide 
(NO) radical scavenging method described previously (Tsikas, 
2007). Ascorbic acid was used as a reference standard and all 
determinations were made in triplicates.
Acute toxicity studies 
Rats were divided into test and control groups (n = 6). The test 
group was given an increasing oral dose (1, 3 and 5 g/kg) of 
extract and its fractions. Rats were allowed food and water ad 
libitum and were kept under regular observation for symptoms 
of mortality and behavioural changes for a 48 h period (Dixon, 
1965; OECD, 2000).
Induction of experimental diabetes 
Diabetes was induced by sub-cutaneous (s.c.) injection of 
streptozotocin (STZ) in a single dose of 45 mg/kg body weight. 
STZ was dissolved in freshly prepared 0.01 M citrate buffer 
(pH 4.5). Animals were allowed to drink 5% glucose solution 
overnight to overcome the drug induced hypoglycemia. Twenty 
four hours after the injection, blood was withdrawn from 
overnight fasting animals and blood glucose level was assessed 
by a glucometer. Fasting animals (8 h) with blood glucose levels 
above 200 mg/dl were selected for the experiment as diabetic 
rats. Control animals were administered normal saline alone 
(Banskota et al., 2006).
Experimental design
Acute antidiabetic studies
The diabetic rats fasted overnight and were divided randomly 
into eleven groups (I–XI) of six rats each (n = 6) as follows: 
Group I, received vehicle (distilled water 10 ml/kg, p.o.); Group 
II, received insulin (4 IU/kg, s.c.); Group III received rutin 
(100 mg/kg, p.o.); Group IV-XI received CTAE extract and its 
fractions in dose range of 100 and 200 mg/kg administered 
orally using oral syringe. After administration, antidiabetic 
activity was assessed by withdrawing blood samples at 0, 1, 3, 
5 and 24 h respectively. Results were reported as mg/dl (Itankar 
et al., 2011).
Sub-chronic antidiabetic studies
Rats were divided into six groups of six rats each 
(n = 6). Group I served as diabetic untreated control. Group II 
served as standard and was treated with 4 IU/kg/day insulin 
(Torrent Pharmaceuticals Ltd., India). Group III received rutin 
(100 mg/kg, p.o.). Group IV-VI received 200 mg/kg of CTAE 
extract; CTACS fraction and CTABS fraction, respectively, orally 
per day for 21 days. Fasting blood glucose levels (8 h fasting) 
and body weight were measured on day 0, 7, 14 and 21 of the 
study (Salahuddin and Jalalpure, 2010). Finally, on day 21, blood 
was collected from retro-orbital plexus, the rats were sacrificed, 
and pancreas removed, cleaned and washed in ice-cold normal 
saline for biochemical and histopathological study.
Pancreatic regeneration study
Tissue processing
Rats were sacrificed and pancreas removed were cleared of fat 
and lymph nodes, weighed and fixed for 1 h in 10% formalin 
and dehydrated by graded alcohol. The tissue was embedded in 
paraffin. Each gland was sectioned serially (4 μm in thickness) 
on a rotary microtome (Shandon, S325, England) along its 
length to avoid any bias due to changes in islet distribution 
or cell composition. For each pancreas, ten sections were 
randomly chosen at a fixed interval through the block (every 
35th section), a procedure shown to ensure the selected 
sections are representative of the whole pancreas (Movassat 
et al., 1997), and stained with haematoxylin and eosin (H and 
E) for histological examination (Ahmed et al., 2010).
 
Histopathological and morphometric analysis
For morphometric analysis, the mean area (μm2) of individual 
islets, perimeter of individual islet as a measure of islet size, 
and number of islet per section was determined on H and 
E-stained section of each group on a Motic digital microscope 
equipped with Motic Image plus 2.0 software (Motic, China). 
To determine the cross-sectional area of focal tissue, sections 
were systematically sampled using an image analysis system. 
Slides were examined in 1.0 x 1.5-mm increments, resulting 
in the assessment of 70 ± 5 fields per slide and 82 ± 5% of the 
total pancreatic section. Individual islets were quantified by 
capturing each field and, computer assisted, hand tracing focal 
areas within the captured images. The thresholding option was 
used to quantify the cross sectional areas occupied by tissue 
and to subtract unstained, unoccupied, areas (white space). 
The magnification was calibrated using a calibration grid 
micrograph. Apoptotic cells were photographed from these 
samples. To evaluate the distribution of islet sizes, islets were 
classified arbitrarily as small (perimeter < 500 μm), medium 
(perimeter between 500-1000 μm), large (perimeter between 
1000-1500 μm), extra large (perimeter between 1500-2000 μm) 
and extra-extra large (perimeter between 2000-2500 μm). 
Estimation of biochemical parameters
The antioxidant enzymes superoxide dismutase (SOD), catalase 
(CAT), glutathione peroxidase (GSH) and lipid peroxidase 
(LPO) were assessed in erythrocyte and pancreas by methods 
described previously (Jamall and Crispin Smith, 1985). Serum 
triacylglycerides (TG), total cholesterol (TC) and high-density 
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lipoproteins (HDL) level was also estimated (Muller et al., 1977) 
using standard kits obtained from Span Diagnostics, India. 
Serum low-density lipoproteins (LDL) and very low-density 
lipoproteins (VLDL) level was calculated by using the following 
formula:
VLDL = TG/5
LDL = TC − (HDL + VLDL)
Acute toxicity studies 
Rats were divided into test and control groups (n = 5). 
The test group was given an increasing oral dose (1, 3 and 
5 g/kg) of TPLE and its fractions. The rats were allowed food 
and water ad libitum and were kept under regular observation 
for symptoms of mortality and behavioral changes over a 
period of 48 h (Dixon, 1965; OECD, 2000).
Statistical analysis
All the data concerning acute and sub-chronic antidiabetic 
study, in vivo antioxidant activity, antihyperlipidemic activity, 
body weight, and morphometric analysis were expressed as 
mean ± SD. Statistical differences between the treatments 
and the controls were tested by two-way analysis of variance 
(ANOVA) followed by Bonferroni posts-test using the 
“GraphPad-Prism” (version 5.02) statistical analysis software. A 
difference in the mean values of p < 0.05 or less was considered 
statistically significant. 
Results
Phytochemical screening
The phytochemical screening of CTAE extract revealed 
the presence of alkaloids, phenolic compounds, tannins, 
flavonoids, carbohydrates, sterols, terpenoids and proteins. 
CTACS fraction showed the presence of tannins, triterpenoids 
and flavonoids; CTABS fraction proved presence of tannins 
and flavonoids; and CTABIS fraction contained alkaloids, 
carbohydrates, proteins, flavonoids, and tannins.
Acute toxicity studies
There was no mortality observed at doses up to 2 g/kg (p.o.) 
in rats. During observation, the animals exhibited decreased 
mobility but no signs of convulsions or loss of writhing reflex. 
This result indicates that CTA extract and its broad fraction 
have a low toxicity profile.
Determination of total polyphenol, flavonoid and flavanones
Total polyphenol content (mg/g) determined by Folin-Ciocalteu 
colorimetric method was 24.24 ± 0.01, 6.51 ± 0.01, 48.06 ± 0.05, 
and 5.77 ± 0.01 (GAE mg/g of extract) for CTAE, CTACS, CTABS 
and CTABIS respectively. Polyphenol content was determined 
by a linear regression equation of gallic acid and expressed 
as GAE of extract (y = 0.009x + 0.028, r2 = 0.996). The flavonoid 
content determined by aluminium chloride method was found 
to be 3.28 ± 0.02, 2.92 ± 0.01, 8.89 ± 0.41 and 2.64 ± 0.02 RE mg/g 
of extracts for CTAE, CTACS, CTABS and CTABIS respectively. 
Flavonoid content was determined from linear regression 
equation of rutin (y = 0.014x - 0.017, r2 = 0.996). The flavanone 
content determined by 2,4-dinitrophenylhydrazine method 
was found to be 1.12 ± 0.02, 0.186 ± 0.01,and 2.89 ± 0.06 and 
0.056 ± 0.09 NE mg/g of extract for CTAE, CTACS, CTABS and 
CTABIS respectively. Flavanone content was determined from 
linear regression equation of naringin (y = 0.156x + 0.564, 
r2 = 0.976). 
As suggested by Chang et al. (2002) the flavones, flavonol 
and isoflavones formed complexes only with aluminium 
chloride, while flavanone strongly reacted only with 
2,4-dinitrophenylhydrazine, so the contents determined by 
the two methods were added up to obtain the total flavonoid 
content. 
The flavonoid and flavanone content represent only 
13.53% (w/w) and 4.62 % (w/w) of the TP in CTAE extract 
respectively and a similar pattern was observed in all its 
fractions, suggesting that the extracts are very complex 
and contain many other polyphenols such as flavanones, 
isoflavones, phenolic acids and tannins, and the degree of 
polymerization of the polyphenols present in the samples is 
high. Degree of polymerization can be estimated by the ratio 
between the TP and TFA contents (Souza et al., 2008). The 
highest polymerization is observed in CTAE fraction and it 
varies from 7.39, 2.9, 5.41 and 2.18 for CTAE, CTACS, CTABS 
and CTABIS respectively. Thus the fractionation of ethanol 
extract CTAE with different solvents resulted in segregation 
of important secondary metabolites i.e. steroids. Moderately 
hydrophobic polyphenols were separated in CTACS fraction, 
while flavonoids and majority of polyphenols were enriched 
in CTABS fraction.
Quantitative estimation of rutin
Rutin extract content and its fraction was found to be 
0.15% w/w, 0.32% and 0.08% w/w in CTAE, CTABS and CTABIS 
respectively. These results demonstrate that fraction of the 
extract resulted in enrichment of flavonoids in n-butanol 
fraction.
In vitro antioxidant studies
To understand the mechanism of antioxidant capacity, 
different analytical methods varying in their oxidation 
initiators and targets were used. Antioxidant capacity 
of an extract greatly depends on its composition and 
the methodology used, for example the oxidant and 
the oxidisable substrate used in the measurement (Cao 
and Prior, 1998). Apart from this, the characteristic of 
a particular test reaction can influence the analysis 
outcome. Some tests are preferential towards hydrophilic 
or hydrophobic compounds, whilst others are insensitive 
in this matter.
The antioxidant activity of the rutin extract and its fractions 
were observed in decreasing order of rutin > CTABS > CTACS 
> CTAE > CTABIS having IC50 (μg/ml) value of 1.26 ± 0.01, 
6.05 ± 0.02, 21.95 ± 0.04, 36.79 ± 0.03, 67.14 ± 0.01 and 
19.79 ± 1.01, 169.63 ± 1.09, 182.25 ± 3.98, 254.47 ± 2.01, 
324.52 ± 6.25 in DPPH and NO scavenging method, respectively. 
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Antihyperglycemic effect 
Acute toxicity studies revealed the non-toxic nature of 
CTAE extract and its fractions. There was no lethality 
or toxic reaction observed up to a dose level of 2 g/kg, p.o. 
The CTAE extract, its fractions, and rutin, have shown to 
induce a significant reduction in blood glucose levels in an 
acute antidiabetic study (Table 1). The insulin (short-acting 
soluble human insulin) at dose level of 4 IU/kg showed 80.98% 
reduction in plasma glucose after 24h (570.5 ± 9.12 mg/dl at 0 
h to 108.53 ± 8.50 mg/dl; p < 0.001). Amongst the extract and its 
fraction CTAE extract has reduced elevated blood glucose level 
to 66.0% dose level of 200 mg/kg, p.o. after 24 h (541.25 ± 14.26 
mg/dl at 0 h to 184.0 ± 7.87 mg/dl; p < 0.001), while comparing 
with the blood glucose at 0 h. Oral administration of rutin also 
significantly reduced 50.19% blood glucose level after 24 h (528 
± 10.61 mg/dl at 0 h to 263 ± 6.78 mg/dl; p < 0.001). The 66.0% 
                        Time (h)
Treatment 0 1 3 5 24
Diabetic Control 553.75 ± 17.97 550 ± 21.6 530.75 ± 7.80 512.75 ± 9.43 473.25 ± 9.07
Insulin (4 IU/kg, s.c.) 570.5 ± 9.12c 383 ± 12.99c 346 ± 17.66c 261.75 ± 16.34c 108.5 ± 8.50c
Rutin (100mg/kg; p.o.) 528 ± 10.61b 457.75 ± 10.37c 419.75 ± 3.59c 365.5 ± 4.04c 263 ± 6.78c
CTAE (100 mg/kg, p.o.) 543.5 ± 15.77 451.75 ± 2.75c 408.25 ± 3.30c 358.75 ± 4.78c 280.25 ± 5.56c
CTAE (200 mg/kg, p.o.) 541.25 ± 14.26 461.75.5 ± 4.43c 387.75 ± 9.26c 254.5 ± 9.11c 184.0 ± 7.87c
CTACS (200 mg/kg, p.o.) 533.25 ± 9.39 455.75 ± 5.56c 419 ± 4.96b 350.75 ± 10.4b 238.75 ± 8.52b
CTABS (100 mg/kg, p.o.) 525 ± 8.40 482 ± 7.83c 458.5 ± 7 402.5 ± 6.80b 316 ± 5.36a
CTABS (200 mg/kg, p.o.) 524 ± 6.38 467.5 ± 6.14b 430.75 ± 10.07b 372 ± 6.78b 282.25 ± 9.57b 
CTABIS (100 mg/kg, p.o.) 531.75 ± 10.78 525 ± 10.63 502.0 ± 9.53a 483 ± 4.32a 461 ± 4.44
CTABIS (200 mg/kg, p.o.) 540 ± 10.36 518 ± 11.40a 497 ± 2.38 473.02 ± 6.78 459.5 ± 8.42a
CTAE, Clitoria ternatea aerial part ethanol extract; CTACS, chloroform soluble fraction of ethanol extract; CTABS, n-butanol soluble fraction of 
ethanol extract.  
aThe data are expressed in mean ± S.D. n = 6 in each group. 
bRepresents statistical significance vs. Diabetic control (p < 0.01).  
cRepresents statistical significance vs. Diabetic control (p < 0.001).
Table 1 
Effect of Clitoria ternatea aerial parts extract and its fraction in acute antidiabetic study.
reduction in blood glucose level exhibited by CTAE extract at 
200 mg/kg p.o. at 24 h seemed to distribute into chloroform 
(CTACS), and n-butanol (CTABS) soluble fractions in 55.23 and 
46.14% respectively. However, CTABIS fraction did not show 
any antidiabetic activity in both the selected doses. None of the 
extract fractions was as potent antidiabetic as insulin. Thus, 
it is evident from the above study that higher antidiabetic 
potential of CTAE extract than its fraction may be because of 
synergistic effect of constituent’s presents in it, which was 
distributed in its fraction.
In a sub-chronic antidiabetic study, it was observed that 
prior to the extract administration there were no significant 
differences between the fasting blood glucose levels of the 
diabetic groups of animals (Fig. 1). However, after three 
weeks, the fasting blood glucose levels of the treated rats were 
significantly lower than the diabetic controls. In contrast, the 
blood glucose level of the untreated diabetic rat remained 
Fig. 1 - Effect of Clitoria ternatea aerial parts extract and selected fraction in sub-chronic antidiabetic study.
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elevated throughout the experimental period. The most 
prominent antidiabetic activity was observed within the CTAE 
and CTABS fractions (66.02 and 59.32%; compared with its 
blood glucose level at day zero) at dose level of 200 mg/kg on 
day 21 of treatment (Table 2). However rutin also decreased the 
fasting (8 h) blood glucose level to 52.34% compared to diabetic 
rats at day zero. Results obtained from this experiment reveal 
that, CTAE extract and its fractions show antidiabetic activity 
in decreasing order of CTAE > CTABS > rutin > CTACS. 
Histological examination, morphometric analysis of islet
In STZ-diabetic rats, the islet is considerably reduced and 
shrunken. There is destruction of some β-cells with central 
hyalinization; a few cells showed pyknotic nuclei and total 
cell number decreased. The degree of atrophy, hydropic 
degeneration, necrosis, hyalinization, or fibrosis was checked 
in H & e stained sections. Many of the islets were degranulated 
and high infiltration of T-cells was observed on treatment with 
STZ (Fig. 2B). 
The average number of islet and average islet area per 
square μm of pancreatic samples was determined by a 
computer assisted measurement Morphometric analysis has 
confirmed that treatment resulted in pancreatic regeneration. 
The size distribution pattern reflected that normal group 
animals islets were larger in size (2000-2500 μm perimeter; 
n = 6) however the larger islet subset were also evident 
in diabetic control group nevertheless these are mostly 
degranulated and having central hyalinization with T-cell 
infiltration (Fig.2. A-B). Similarly, the average number of islets 
(0.87 ± 0.02 × 10-4 vs. 5.1 ± 0.16 × 10-4 in the control group) was 
82.98% less abundant and islet density (2.89 ± 0.09 vs. 3.29 ± 
0.24 per sq. μm of pancreas in normal rats) was 91.23% less in 
per sq. μm of pancreas compared to normal rats. On the other 
hand, average area of islet increased 1.52 fold (769.9 ± 12.9 vs. 
1167.8 ± 23.7 in diabetic control; p < 0.05) in diabetic rats than 
normal rats. Whereas insulin and rutin administration for 21 
days also resulted in the increase of islets less than 500 μm 
in size representative of islet regeneration. Comparing with 
the diabetic group, the average number of islet per sq. μm of 
pancreas increased by 3.22 and 4.72 fold in the insulin and 
rutin group respectively. On the other hand, compared to the 
diabetic control, islet density improved by 173.95% in insulin 
group (5.01 ± 0.16 × 10-4 vs. 2.8 ± 0.02 × 10-4 in diabetic control) 
and 240.28% in rutin treated group (0.69 ± 0.09 vs. 0.29 ± 0.09 in 
diabetic controls) (Fig. 2 A-D). Thus, from the previous study 
(sub-chronic antidiabetic study) and morphometric analysis 
it was evident that rutin possesses pancreatic regeneration 
potential and these results are in agreement with previous 
studies (Guz et al., 2001)
Treatments with CTAE fraction and CTABS extract resulted 
in improvement in β-cell granulation and reduced necrosis, 
hyalinization, or fibrosis of islets compared to diabetic control 
rats. However, treatments with CTACS fraction for 21 days 
resulted in partial improvement in pancreatic tissue integrity. 
The number of T-infiltrated and degranulated islet cells were 
Treatment 
Distribution of Islet size
 (μm; perimeter)
Distribution of islet as per size
Normal 
Control
Diabetic 
Control
Insulin 
(4 IU/kg s.c.)
Rutin 
(100 mg/kg; p.o.)
CTAE 
(200 mg/kg; p.o.)
CTACS
 (200 mg/kg; p.o.)
< 500 2 ± 0.15 0 6 ± 0.15 16.6 ± 0.23 17.2 ± 1.29 10 ± 1.2a 12.46 ± 0.58
500 - 1000 2 ± 0.3 0 4 ± 0.12 3 ± 0.18b 4 ± 0.13a 1 ± 0.17 2 ± 0.24
1000 - 1500 4 ± 0 1 ± 0.21 2 ± 0.6  2 ± 0.52 3 ± 0.05 1 ± 0.82 1.18 ± 0
1500 - 2000 4 ± 0.01 4 ± 0.08 0 1 ± 0.02 1 ± 0.02a 0 2 ± 0.2
2000 - 2500 5 ± 0.21 4 ± 0.001 2 ± 0.11 0 0.35 ± 0.01 0
0
Average no. of islet per  
sq. μm of pancreas (x 10-3)
0.51 ± 0.016b 0.0868 ± 0.0021 0.28 ± 0.002 0.41 ± 0.08a 0.712 ± 0.022b 0.43 ± 0.001b 0.625 ± 0.085b
Average size of islet (μm2 x 10-3) 769.9 ± 12.9a 1167.8 ± 23.7c 845.4 ± 49.8c 328.5 ± 15.2a 296.8 ± 15.3a
3a 162.4 ± 18.5a 239.2 ± 12.6b
Average Islet area per  
sq. μm of pancreas
3.285 ± 0.24b 0.288 ± 0.186 0.501 ± 0.012 0.692 ± 0.09a 0.9235 ± 0.03a 0.512 ± 0.09a 0.806 ± 0.003a
CTAE, ethanol extract; CTACS, chloroform soluble fraction of ethanol extract; CTABS, n-butanol soluble fraction of ethanol extract.
The data are expressed in mean ± S.E.M. n = 6 in each group.
The perimeter (μm) of islet size in 10 sheets of sections/rats was measured. The data are expressed in mean ± S.D n = 6 in each group. 
ap < 0.05. 
bp < 0.01.
cp < 0.001.
Table 2 
Effect of Clitoria ternatea aerial parts extract and its selected fractions on islet size and distribution pattern in STZ-induced 
diabetic rats after treatment for 21 days.
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reduced in CTACS fraction compared to diabetic control group. 
Morphometric analysis confirmed that treatment has resulted 
in pancreatic regeneration. The size distribution pattern has 
revealed the presence of higher number of smaller islets 
(≤ 500 μm in perimeter) in CTAE fraction (17.2 ± 1.29; p < 0.001 
resp.) compared to rutin treated, normal and diabetic control 
group, thus indicating the formation of neo-islets. Similarly, 
CTACS and CTABS fractions resulted in the increase of islets 
numbers, however it is less pronounced than in the rutin 
treated group. 
The average number of islet increased in CTAE and 
CTABS by 8.20 and 7.20 fold (0.87 ± 0.02 vs. 7.12 ± 0.22 and 
6.25 ± 0.85 in CTAE and CTABS group, respectively) compared 
to the diabetic control group, and these effects were more 
pronounced than insulin and rutin treated groups. Similarly, 
a 320.66 % and 279.86 % increase in the average islet area 
per sq.μm was observed in CTAE and CTABS treated groups 
compared to diabetic control after treatment for 21 days 
respectively. However, the average islet area of CTAE and 
CTABS treated group was only 38.55% and 31.06% of islet area 
of normal control group. Treatment with CTACS fraction had a 
very marginal improvement in islet size area and distribution 
pattern compared to the insulin group, but it was less effective 
than rutin treated group. The pancreatic regeneration potential 
exhibited by rutin treatment was less pronounced than that of 
the CTAE fraction (Table 2). 
In vivo antioxidant activities in erythrocytes and pancreas
The in vivo antioxidant enzyme activity in the erythrocytes 
and pancreas of normal and diabetic groups were assessed. 
In general, normal groups maintained higher enzyme levels 
of SOD, CAT, GSH and lower LPO levels than diabetic groups, 
(Sarkhail et al., 2007). Daily administration of extract and its 
Fig. 2 - Hematoxylin and eosin stained histopathological sections of pancreas after 21 days treatment (A) Normal control: 
Native architecture of islet and pancreatic tissue (B) Diabetic control: Islet of Langerhans displaying degenerative & 
necrotic changes in diabetic control rats (C) Insulin group: Islet of Langerhans displaying degenerative changes and less β 
cell granulation compare to normal rats (D) Rutin group: Islet of Langerhans displaying increase in size with degenerative 
changes compared to normal control group . (E) CTAE group: Islet of Langerhans displaying increase in size and increased 
granulation compared to diabetic control group, islet architecture similar to normal control group (F) CTACS group: Enlarged 
islet of Langerhans with light degenerative few changes in (G) CTABS group: Newly formed islet of Langerhans with 
degeneration (H) Showing the regeneration of neo islets from the intralobular duct. 1, Newly formed islet.2, Intralobular 
duct from which the islet sprouted. 3, Glandular Acinus. 4, Intralobular connective tissue septa. 5, Blood vessels Blue Arrow. 
Connection between the duct and the islet.
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fractions were effective in fully recovering the enzyme activity, 
as level detected in normal group animals. Treatment with 
rutin, CTAE, CTACS and insulin significantly increased levels 
of SOD, CAT and GSH and decreased elevated LPO levels near 
to normal in both erythrocytes and pancreas in diabetic groups 
(Table 3).
Therefore, the extract and or fractions showing antidiabetic 
potential by reducing the production of ROS by inhibiting auto-
oxidation of glucose elicit in-vivo antioxidant potential. 
Effect on body weight and lipid profile
There was no significant intra-group variation in the basal 
body weight of the rats at day zero. However, at the end of 21 
days of treatment the body weight of the rats in the normal 
group, insulin group, rutin, CTAE, CTACS and CTABS treated 
group, increased significantly by 22.5%, 18.83%, 16.11%, 17.83%, 
11.17% and 16.41% respectively; whereas the body weight of 
diabetic control group decreased by 22.5%.
In the present study, diabetic rats treated with rutin, CTAE 
extract and its fractions showed an increase in body weight 
as compared to the diabetic control, which may be due to its 
protective effect in controlling muscle wasting (reversal of 
gluconeogenesis). The most potent reduction in elevated TC, 
TG, and LDL was observed within the insulin group and CTAE 
extract. Treatment with CTAE extract for 21 days resulted 
in 50.28%, 72.78% and 64.55% reduction in plasma LDL, TG 
and total cholesterol, while 215.90% increase in HDL level 
in comparison to diabetic control. Similarly, TC: HDL ratio 
and LDL: HDL ratios were significantly improved by -76.76%, 
-83.27% in CTAE treated group, as compared to diabetic control. 
Treatment with CTACS and CTABS fraction have shown a 
moderate decrease of elevated TC, TG and LDL levels, on the 
other hand rutin a naturally occurring bioflavonoid shows a 
lower efficacy in management of lipid profile in comparison to 
selected fractions of C. ternatea and its extract (Table 3). 
Discussion
The most potent antioxidant activity was proven by rutin in 
both the assays. However, the higher antioxidant potency of 
extract and its fractions in DPPH assay in comparison to the NO 
assay can be explained as both DPPH and NO assays measure 
the free radical-scavenging activity but DPPH is carried out 
in an organic environment (an alcohol for example), while 
NO assay requires a buffered aqueous solution. Although 
the NO assay is carried out in an aqueous buffer, the nitric 
oxide molecule itself is a lipophilic species, hence it has a 
higher compatibility to such compounds that could both 
disperse well in the buffer and interact with the free radical. 
Amongst the extract and its fractions, CTABS fraction showed 
the highest antioxidant potential in both assays. These results 
are in agreement with its chemical content, as fractionation 
of extract resulted in enrichment of polyphenol and flavonoid 
components in the CTABS fraction, which as a resolut showed 
a higher antioxidant activity than CTAE extract. These findings 
suggested that there could be a correlation between the 
higher content of total polyphenol, flavonoid contents and its 
antioxidant potential.
Antidiabetic studies reveal that, CTAE extract and its 
fractions have sub-chronic antidiabetic activity in decreasing 
order CTAE > CTACS > CTABS > Rutin. The higher potential 
of CTACS fraction over CTABS extract, which contains 
higher amount of polyphenol and flavonoids, suggests 
that fractionation increases the degree of polymerization 
and segregation of secondary metabolites such as sterols, 
terpenoids and complex polyphenols that may results in 
increase antidiabetic potential. In contrast to all the fraction 
and extract in sub-chronic antidiabetic study, the lower 
antidiabetic potential of well-known bioflavonoid, rutin, 
may be caused of synergistic effects with different secondary 
metabolites present in the fraction and extract. 
Treatment TC TG HDL LDL VLDL
Normal Control 76.1 ± 3.51 35.94 ± 3.24 27.27 ± 4.72 41.65 ± 2.04 7.19 ± 0.65
Diabetic Control 155.33 ± 2.40 156.67 ± 1.67 13.71 ± 0.38 110.29 ± 2.97 31.33 ± 0.33
Insulin (4IU/kg, s.c.) 74.2 ± 2.62
c 43.48 ± 1.38c 27.05 ± 0.25c 38.45 ± 2.61c 8.70 ± 0.28c
Rutin (100 mg/kg, p.o.) 84.25 ± 2.6
c 60.76 ± 0.28c 19.03 ± 1.03 53.07 ± 3.05c 12.15 ± 0.06c
CTAE (200mg/kg, p.o.) 77.23 ± 1.43
c 42.65 ± 1.33c 29.6 ± 2.43c 39.10 ± 1.90c 8.53 ± 0.27c
CTACS (200 mg/kg, p.o.) 81.49 ± 0.64
c 57.17 ± 2.50c 20.32 ± 0.53 49.74 ± 1.56c 11.43 ± 0.50c
CTABS (200mg/kg, p.o.) 79.27 ± 2.67c 55.93 ± 3.68c 20.82 ± 1.9a 47.27 ± 3.70c 11.18 ± 0.74c
The data are expressed in mean ± S.E.M. n = 6 in each group.
aRepresents statistical significance vs. diabetic control (p < 0.05).
bRepresents statistical significance vs. diabetic control (p < 0.01).
cRepresents statistical significance vs. diabetic control (p < 0.01).
Table 3 
Effect of aerial parts of Clitoria ternatea and leaves of Tephrosia purpurea extract and their fractions on lipid profile of diabetic 
rats.  
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Previous studies have shown that there is a close 
relationship between the increase of free radicals, blood 
glucose and lipid peroxidation (LPO) in diabetes progression 
(Reddy et al., 2005). Increased LPO impairs membrane function 
by decreasing membrane fluidity and changing the activity of 
membrane-bound enzymes and receptors.
Enzymatic antioxidants such as SOD and CAT are 
considered as primary enzymes since they are involved in the 
direct elimination of reactive oxygen species (ROS) (Arulselvan 
and Subramanian, 2007). SOD is an important defense enzyme, 
it scavenges O2- anions from H2O2 and hence diminishes 
the toxic effects of this and other free radicals derived from 
secondary reactions. CAT is a hemoprotein, which catalyzes 
the reduction of hydrogen peroxides and is known to be 
involved in detoxification of H2O2 concentrations in vivo.
Furthermore, in our study the activity of SOD, CAT and GSH 
decreased in the diabetes group as reported earlier (Gokce 
and Haznedaroglu, 2008) which could be due to involvement 
in the elimination of ROS generated by STZ. Treatment of 
diabetes with the extract and fractions reversed the activity 
of these enzymatic antioxidants, which might be due to the 
involvement in decreased oxidative stress as evidenced by the 
decrease of LPO. These findings suggest that CTAE induces in 
vivo antioxidant activity by attenuating the lipid peroxidation 
caused by various forms of free radicals; in this way may affect 
lipid profile in diabetes. The in vivo antioxidant activity of the 
rutin, extract and its fractions were observed in decreasing 
order of CTAE > CTACS > CTABS > rutin. The in vivo antioxidant 
pattern observed is inverse from its in vitro antioxidant pattern. 
This can be explained as the elevated blood glucose level in 
diabetes, not only generates ROS but also attenuates anti-
oxidative mechanisms by scavenging enzymes and antioxidant 
substances. Since the glucose toxicity causes abnormal fatty 
acid metabolism, as auto-oxidation of glyceraldehyde, which 
generates hydrogen peroxide and a ketoaldehydes and this 
can lead to chronic oxidative damage (Shahat et al., 2004). The 
decrease in body weight associated to diabetes mellitus has 
been attributed to the gluconeogenesis leading to increased 
muscle wasting and loss of tissue proteins (Shirwaikar et al., 
2005). Thus, the ability of CTAE extract and its fractions to 
effectively control the increase in blood glucose levels in the 
diabetic group of rats and significantly increasing the body 
weight may be attributed to its antihyperglycemic activity. 
The most commonly observed lipid abnormalities in 
diabetes are hypertriglyceridemia and hypercholesterolemia. 
A marked increase in total cholesterol and a decrease in 
HDL cholesterol have been observed in diabetic control rats. 
Insulin deficiency results in failure to activate lipoprotein 
lipase thereby causing hypertriglyceridemia. In diabetes LDL 
and VLDL carry cholesterol to the peripheral tissues where 
it is deposited, whereas HDL transports cholesterol from 
peripheral tissues to the liver and thus aids its excretion. 
Hence the increase in LDL and VLDL is atherogenic. There 
was a significant control of serum lipids level in CTAE-treated 
diabetic rats.
Hence, the ability of CTAE extract and its fractions to 
effectively control the increase in blood glucose in the 
diabetic group and significantly increase the body weight 
may be attributed to its antihyperglycemic activity. Thus 
from the above results, it is observed that the efficiency of 
lipid level reductions is associated with its potential to treat 
hyperglycaemia. This observation is further supported by 
histopathological studies of CTAE extract treated rats; there 
is evidence of nesidioblastosis, as can be seen by the intact 
ductal connection between the islet and associated duct in 
the pancreas of CTAE-treated rat (Fig. 2F). This results are in 
agreement with previous published data showing reversal 
of diabetic mice by formation of new islets from ductal cells 
(Kodama et al., 2003). 
The notion that recruitment of β cells from a precursor 
pool may remain active in adulthood is supported by the 
observations that even in the adult rat pancreas some islets 
are still closely connected to ducts. Moreover, it was recently 
demonstrated that adult β-cell de novo formation from ductal 
cells is inducible. It is evident that the regenerating pancreas 
has the potential to induce islet neogenesis in the STZ-induced 
diabetic animals. These newly formed islets were then seen 
to grow into larger mature islets, probably by islet β-cell 
replication. The increase in islets size both in insulin and 
diabetic control groups, is a result of continuously increasing 
functional demand to which the residual β-cells are exposed 
and in order to compensate for their decreased cell number 
(Wang et al., 1996). Rutin, by its ability to scavenge free radicals 
and to inhibit lipid peroxidation, prevents streptozotocin-
induced oxidative stress and protects β-cells resulting in 
increased insulin secretion and decreased blood glucose 
levels. In this context, research by Vessal et al. (2003) have 
shown that quercetin, the aglycone form of rutin, decreased 
blood glucose concentration and increased insulin release in 
streptozotocin-induced diabetic rats. Coskun et al. (2005) have 
also reported that, in streptozotocin-induced diabetic rats, 
quercetin protected pancreatic β-cells integrity by decreasing 
oxidative stress. Increased insulin levels could also be due 
to the stimulatory effect of rutin, thereby potentiating the 
existing β-cells of the islets of Langerhans in diabetic rats. Hii & 
Howell (1984;1985)reported an increased number of pancreatic 
islets in quercetin treated animals. It can be concluded that 
CTAE extract possess most potent antidibetic and significant 
in-vivo antioxidant activity by virtue of its capacity to cause 
pancreatic regeneration. The near normoglycemia achieved 
by the CTAE extract is either due to the formation of neo-islets 
rich in β-cells granulation or by the replication or expansion of 
the existing residual islets. These neo-islets formed by CTAE 
stimulation resulted in a decrease of fasting blood glucose level 
by increased insulin secretion, which also prevents atrophy by 
opposing to ubiquintin-proteasome pathway. This in turn 
helps in pancreatic regeneration, decrease in oxidative stress 
decrease in diabetes induced elevated lipid levels and decrease 
level of SOD, GSH and CAT enzyme activity.
It is evident from the study that C. ternatea exhibited 
significant pancreatic regeneration activity in STZ-induced 
diabetic rats. CTAE extract & its fractions proved relevant 
for the improvement in parameters like body weight & lipid 
profile and as a consecuence, their use might be of value in the 
treatment of diabetes.
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